脱氢抗坏血酸

脱氢抗坏血酸（CAS 490-83-5）的独立参考数据，整理自公开化学数据库。

各数据库的登记标识

计算分子描述符

在册的理化数值

在册的记载用途

There is no approved indication for dehydroascorbic acid, but it has potential therapeutic use in patients with certain viruses and ischemic stroke.Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body.

同义词与商品名

DEHYDROASCORBIC ACID; 490-83-5; L-Dehydroascorbic acid; DHAA; Dehydro-L-ascorbic acid; L-Threo-hexo-2,3-diulosono-1,4-lactone; (5R)-5-[(1S)-1,2-dihydroxyethyl]oxolane-2,3,4-trione; L-threo-2,3-Hexodiulosonic acid, gamma-lactone; Y2Z3ZTP9UM; CHEBI:27956; DTXSID00912316; (5R)-5-[(1S)-1,2-dihydroxyethyl]furan-2,3,4(5H)-trione; (5R)-5-((1S)-1,2-DIHYDROXYETHYL)FURAN-2,3,4(5H)-TRIONE; Acid, Dehydroascorbic; CHEBI:17242; (5R)-5-((1S)-1,2-dihydroxyethyl)oxolane-2,3,4-trione

GHS 危害分类

Reported hazard statements	H302 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

公开数据库对它的描述

dehydroascorbic acid · CAS 490-83-5 · C6H6O6. UNII Y2Z3ZTP9UM. Melting Point: Decomposes at 225°C (437°F); Dissociation Constants: 3.90; Collision Cross Section: 128.2 Ų [M-H]-.

物理形态与操作说明

数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。